August 4, 2026

@michaelokun

One of the discussions that really resonated with me at the Aspen Movement Disorders Course was why some people with Wilson's disease have a much more difficult clinical course than others, even when they receive appropriate treatment. Susan Fox shared a memorable case of hers highlighting white matter changes on MRI, which sparked an important conversation about emerging evidence that genetics may help explain these differences. Early studies suggest that patients carrying loss-of-function variants in the ATP7B gene may experience worse transplant-free survival despite chelation therapy, raising the possibility that genotype may one day help guide prognosis, counseling, and perhaps even individualized treatment strategies. We are still in the early chapters of this story, but it is an important reminder that Wilson's disease is not a single disease with a single trajectory. Understanding the biology underlying these genetic differences may ultimately help explain why some patients respond remarkably well while others face a much more challenging journey.